Neuronal Plasticity Assay Services
The brain's adaptability—neuroplasticity—is fundamental to healthy function, but disruptions lie at the heart of devastating neurological conditions like Alzheimer's disease (AD) and Parkinson's disease (PD). At Creative Biolabs, we empower your research with comprehensive in vitro neuroplasticity testing. From pinpointing molecular changes to mapping complex network dynamics, we provide the data you need to accelerate drug development and bring hope to patients.
Introduction of Neuronal Plasticity
![]() |
Neuronal plasticity, the brain's remarkable ability to reorganize itself, is fundamental to how we learn, adapt, and recover from injury. This dynamic process, involving changes in synaptic strength and neuronal connectivity, underlies everything from forming new memories to recovering motor function after a stroke. |
At its core, neuronal plasticity reflects the brain's constant adaptation to experience. This adaptability manifests in a variety of ways:
- Synaptic Plasticity
Changes in the strength of connections between neurons, crucial for learning and memory. Long-term potentiation (LTP) and long-term depression (LTD) are key mechanisms.
- Structural Plasticity
Physical changes in the brain's structure, such as the growth of new synapses or the formation of new neurons (neurogenesis).
- Functional Plasticity
Reorganization of brain regions to take on new functions, often seen after brain injury.
Comprehensive Cell and Animal Models for Neuroplasticity Research
To accurately model the complexities of neuroplasticity, we offer a full spectrum of in vitro and in vivo platforms, designed to provide robust and translatable data.
- Humanized Cell Models for Realistic Microenvironments
Astrocytes, Microglia, and Blood-Brain Barrier (CMEC/D3): Our humanized cell models recreate the intricate neural microenvironment, allowing for the study of cell-cell interactions and the impact of the blood-brain barrier on drug delivery. These models are crucial for understanding how different cell types contribute to neuroplasticity and disease progression.
- Disease-Specific Models for Targeted Research
AD (β-amyloid aggregation), PD (α-synuclein analysis), Fragile X Syndrome, and More: We provide a range of disease-specific models that accurately reflect the pathological hallmarks of neurological disorders. These models enable researchers to validate therapeutic targets and screen potential drug candidates with high fidelity.
- Advanced Gene Editing Tools for Molecular Insights
Tau Antisense Oligonucleotides, SOD1 Adenovirus Silencing, and Custom Solutions: Our gene editing capabilities empower researchers to precisely manipulate gene expression and analyze the molecular mechanisms underlying neuroplasticity. We offer solutions like Tau ASOs and SOD1 silencing, as well as custom gene regulation strategies, to support your research needs. This allows for accurate analysis of molecular mechanisms related to plasticity.
Neuronal Plasticity Assays
As a professional CRO company, our in vitro neuroplasticity testing services encompass a wide range of capabilities, including:
Neurogenesis Assay | Synaptogenesis Assay |
Neurite Outgrowth/Degeneration Assay | Synaptic Imaging Assay |
For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Rat Muller Cell (Cat#: NCL2110P040)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)